Contralateral Prophylactic Mastectomy is Associated with a Survival Advantage in High-Risk Women with a Personal History of Breast Cancer
Authors:
- 19 September 2010
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 17 (10) , 2702-2709
Abstract
Background The aim of this study was to investigate whether contralateral prophylactic mastectomy (CPM) in addition to therapeutic mastectomy (TM) is associated with a survival advantage in high-risk...Keywords
This publication has 24 references indexed in Scilit:
- Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer PatientsJNCI: Journal of the National Cancer Institute, 2010
- Increasing Rates of Contralateral Prophylactic Mastectomy Among Patients With Ductal Carcinoma In SituJournal of Clinical Oncology, 2009
- Incidence and outcomes of contralateral breast cancersThe American Journal of Surgery, 2008
- Increasing Use of Contralateral Prophylactic Mastectomy for Breast Cancer Patients: A Trend Toward More Aggressive Surgical TreatmentJournal of Clinical Oncology, 2007
- Society of Surgical Oncology: Position Statement on Prophylactic Mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007Annals of Surgical Oncology, 2007
- Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us?Breast Cancer Research and Treatment, 2007
- Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer casesEuropean Journal of Cancer, 2007
- Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivorsBreast Cancer Research and Treatment, 2006
- Survival and prognostic factors in BRCA1-associated breast cancerAnnals of Oncology, 2005
- Satisfaction After Contralateral Prophylactic Mastectomy: The Significance of Mastectomy Type, Reconstructive Complications, and Body AppearanceJournal of Clinical Oncology, 2005